Wednesday, September 19, 2018Canada's Leading Online Business Magazine
Business News

Professional Services News

Avid Bioservices Reports Financial Results for First Quarter Fiscal 2019 and Recent Developments

– Fiscal 2019 Projected Revenue of $51 to $55 Million Reaffirmed – – Multiple Projects Advanced During the Quarter – – Initiated Operations of New Process [...]

Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock

TUSTIN, Calif., Sept. 05, 2018 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to [...]

Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2019 After Market Close on September 10, 2018

TUSTIN, Calif., Sept. 04, 2018 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to [...]

Avid Bioservices to Present at Upcoming Investor Conferences

TUSTIN, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) [...]

Avid Bioservices to Exhibit at the 2018 BioProcess International Conference & Exhibition

– Corporate Booth to Include Virtual Tour of Myford Late-Stage Clinical and Commercial Biomanufacturing Facility Highlighting Immediately Available 2,000-Liter Scale Bioreactor Capacity [...]

Avid Bioservices to Exhibit at the Bioprocessing Summit 2018

TUSTIN, Calif., Aug. 08, 2018 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) [...]

Avid Bioservices Announces Appointment of Daniel Hart as Chief Financial Officer

– Senior Executive with Extensive Financial Leadership Experience Further Strengthens Management Team; Company Also Adds Senior Director of Business Development for Western Region to [...]

Avid Bioservices Reports Financial Results for Quarter and Fiscal Year Ended April 30, 2018 and Recent Developments

– Company Records Fiscal Year 2018 Revenue of $53.6 Million – – Committed Backlog Increases to $57.8 Million (ASC 605) – – Customer Base Expanded and Diversified [...]

Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2018 After Market Close on July 16, 2018

TUSTIN, Calif., July 09, 2018 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to [...]

Avid Bioservices Added to Russell 3000® Index and Russell 2000® Index

TUSTIN, Calif., June 25, 2018 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) [...]

page  1  of  41